Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
Clinical trial NCT05334277 · RECRUITING
Trial details
- NCT number
- NCT05334277
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-06
- Primary completion
- 2025-02-28
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.